| Stago

Stago Announces Exciting New Partnership with Awanui

Diagnostica Stago, the experts in Coagulation, are thrilled to announce a strategic partnership with Awanui, a renowned innovator in the delivery of healthcare in New Zealand.

A new look for Stago's scientific posters

A new look for Stago's scientific posters

We are delighted to announce that Stago's popular educational posters have been updated!

(Re)Discover our new posters on :

The new version of the Quick Guide to Hemostasis is available!

The complete guide to hemostasis is back, in a completely updated and redesigned version. Alongside 11 in-depth chapters, it includes diagrams and tables to enhance understanding of hemostasis mechanisms.

sthemO on LinkedIn!

On 27 March, Stago is launching a new LinkedIn page dedicated solely to sthemO. Are you ready for the new chapter in Stago's history?

Follow our sthemO dedicated page on Linkedin.

COVID-19 infection and thrombotic disorders

Since December 2019, COVID-19 is spreading worldwide and affecting people every day. Main symptoms are fever and cough, and most of patients recover spontaneously.

Stago Webinar available on-demand!

The Stago webinars have successfully gathered colleagues from all around the world. If you have missed the live events or are interested in reviewing it, the 30-minute recorded version is now available online 24/7.

5th volume in Stago’s “Practical Manual in Haemostasis” collection

The last two volumes were devoted to anticoagulants (parenteral, then oral), it made sense that the Clinical Development Department had to turn its attention to another side with the exploration of bleeding disorders.

ST Genesia launched!

The ST Genesia was officially launched at an event held in the Synapse church of Maastrich on the 14th of June 2018.

Stago continues to ditch paper!

In April 2017, Stago officially launched its IFU (Instruction for Use) platform at www.stago.com so that customers worldwide could visit and download reagent instructions, analyser reference manuals and safety data sheets that they need for their day-to-day work.

STA-Liatest D-Di receives full 510(k) clearance from US FDA for DVT & PE exclusion

On December 10th, 2016 the US Food and Drug Administration (FDA) cleared STA-Liatest D-Di for the exclusion of the diagnosis of Deep Vein Thrombosis (DVT) on data reported from the multi-national, DiET study. Exclusion of the diagnosis of Pulmonary embolism (PE) was previously 510(k) cleared in 2014.

Subscribe to